E Pett1, K Saeed, M Dryden. 1. Royal Hampshire County Hospital, Hampshire Hospitals NHS Foundation Trust, Romsey Rd, Winchester, Hampshire, UK, eleanor.pett@gmail.com.
Abstract
PURPOSE: Fusobacterium species infections are rare. Recently, however, this potentially deadly pathogen has been attracting interest, and efforts are being made to characterise its epidemiology and clinical spectrum of disease. The aim of our study is to provide further evidence towards this cause, in what is, to date, the largest study of its kind from the UK. METHOD: A 22-year, retrospective, descriptive study was performed at Royal Hampshire County Hospital. An electronic database was used to identify patients with microbiologically confirmed infection with Fusobacterium, and clinical records were examined to provide further information on the presentation, source, treatment and outcome. RESULTS: Fusobacterium species infections were identified in 18 patients during the study period, which is an incidence of 0.76 cases/100,000/year. The overall death rate was 29 %. Half of these patients had Fusobacterium necrophorum infections and were a predominantly young, fit and uniquely male population who had excellent outcomes. Among the remaining patients with Fusobacterium species infections, 22 % had infection with F. varium and 11 % with F. nucleatum. These patients were an older cohort who tended to have co-morbidities and unsurprisingly worse outcomes. We identified a number of Fusobacterium bacteraemias likely to have resulted from pressure ulcers, a presentation that has been rarely reported. Interestingly, we also identified a case of neonatal F. nucleatum bacteraemia that was not associated with premature nor stillborn birth. CONCLUSION: As work continues to depict the spectrum of disease caused by this enigmatic bacterium, it is hoped that improved clinical suspicion will result in better outcomes and management.
PURPOSE:Fusobacterium species infections are rare. Recently, however, this potentially deadly pathogen has been attracting interest, and efforts are being made to characterise its epidemiology and clinical spectrum of disease. The aim of our study is to provide further evidence towards this cause, in what is, to date, the largest study of its kind from the UK. METHOD: A 22-year, retrospective, descriptive study was performed at Royal Hampshire County Hospital. An electronic database was used to identify patients with microbiologically confirmed infection with Fusobacterium, and clinical records were examined to provide further information on the presentation, source, treatment and outcome. RESULTS:Fusobacterium species infections were identified in 18 patients during the study period, which is an incidence of 0.76 cases/100,000/year. The overall death rate was 29 %. Half of these patients had Fusobacterium necrophoruminfections and were a predominantly young, fit and uniquely male population who had excellent outcomes. Among the remaining patients with Fusobacterium species infections, 22 % had infection with F. varium and 11 % with F. nucleatum. These patients were an older cohort who tended to have co-morbidities and unsurprisingly worse outcomes. We identified a number of Fusobacteriumbacteraemias likely to have resulted from pressure ulcers, a presentation that has been rarely reported. Interestingly, we also identified a case of neonatal F. nucleatumbacteraemia that was not associated with premature nor stillborn birth. CONCLUSION: As work continues to depict the spectrum of disease caused by this enigmatic bacterium, it is hoped that improved clinical suspicion will result in better outcomes and management.
Authors: Mauro Castellarin; René L Warren; J Douglas Freeman; Lisa Dreolini; Martin Krzywinski; Jaclyn Strauss; Rebecca Barnes; Peter Watson; Emma Allen-Vercoe; Richard A Moore; Robert A Holt Journal: Genome Res Date: 2011-10-18 Impact factor: 9.043
Authors: Aleksandar D Kostic; Dirk Gevers; Chandra Sekhar Pedamallu; Monia Michaud; Fujiko Duke; Ashlee M Earl; Akinyemi I Ojesina; Joonil Jung; Adam J Bass; Josep Tabernero; José Baselga; Chen Liu; Ramesh A Shivdasani; Shuji Ogino; Bruce W Birren; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson Journal: Genome Res Date: 2011-10-18 Impact factor: 9.043
Authors: Yiping W Han; Yann Fardini; Casey Chen; Karla G Iacampo; Victoria A Peraino; Jaime M Shamonki; Raymond W Redline Journal: Obstet Gynecol Date: 2010-02 Impact factor: 7.661
Authors: Peter D Karkos; Sheetal Asrani; Christos D Karkos; Samuel C Leong; Evangelia G Theochari; Thalia D Alexopoulou; Assimakis D Assimakopoulos Journal: Laryngoscope Date: 2009-08 Impact factor: 3.325
Authors: Se Ju Lee; Yae Jee Baek; Jin Nam Kim; Ki Hyun Lee; Eun Hwa Lee; Joon Sup Yeom; Jun Yong Choi; Nam Su Ku; Jin Young Ahn; Jung Ho Kim; Su Jin Jeong Journal: PLoS One Date: 2022-04-14 Impact factor: 3.752
Authors: Rafael Garcia-Carretero; Marta Lopez-Lomba; Blanca Carrasco-Fernandez; Maria Teresa Duran-Valle Journal: J Crit Care Med (Targu Mures) Date: 2017-11-08